Whole exome sequencing (WES) is a widely used strategy for detection of protein coding and splicing variants associated with inherited diseases. Many studies have shown that the strategy has been broad and proficient due to its ability in detecting a high proportion of disease causing variants, using only a small portion of the genome. In this review we outline the main steps involved in WES, the comprehensive analysis of the massive data obtained including the genomic capture, amplification, sequencing, alignment, curating, filtering and genetic analysis to determine the presence of candidate variants with potential pathogenic/functional effect. Further, we propose that the multiple autoimmune syndrome, an extreme phenotype of autoimmune d...
Background: De novo variants (DNVs) are currently not routinely evaluated as part of diagnostic whol...
Background: Parkinson’s disease (PD) is a complex disease with its monogenic forms accounting for le...
analysis to predict the analytic sensitivity of WES using pathogenic variants identified on targete...
Whole exome sequencing (WES) is a widely used strategy for detection of protein coding and splicing ...
Background: Multiple autoimmune syndrome (MAS), an extreme phenotype of autoimmune disorders, is a v...
Background: Multiple autoimmune syndrome (MAS), an extreme phenotype of autoimmune disorders, is a v...
The recent advent of next-generation sequencing technologies has dramatically changed the nature of ...
International audienceThe advent of next-generation sequencing (NGS) in 2010 has transformed medicin...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Background: De novo variants (DNVs) are currently not routinely evaluated as part of diagnostic whol...
Primary immunodeficiencies (PIDs) are a heterogeneous group of monogenic inborn errors of immunity. ...
Whole exome sequencing (WES) is a recently developed technique in genetics research that attempts to...
Background: De novo variants (DNVs) are currently not routinely evaluated as part of diagnostic whol...
Background: Parkinson’s disease (PD) is a complex disease with its monogenic forms accounting for le...
analysis to predict the analytic sensitivity of WES using pathogenic variants identified on targete...
Whole exome sequencing (WES) is a widely used strategy for detection of protein coding and splicing ...
Background: Multiple autoimmune syndrome (MAS), an extreme phenotype of autoimmune disorders, is a v...
Background: Multiple autoimmune syndrome (MAS), an extreme phenotype of autoimmune disorders, is a v...
The recent advent of next-generation sequencing technologies has dramatically changed the nature of ...
International audienceThe advent of next-generation sequencing (NGS) in 2010 has transformed medicin...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Our understanding of immunity has historically been informed by studying heritable mutations in both...
Over the past several years whole exome sequencing (WES) by high-throughput sequencing of target-enr...
Background: De novo variants (DNVs) are currently not routinely evaluated as part of diagnostic whol...
Primary immunodeficiencies (PIDs) are a heterogeneous group of monogenic inborn errors of immunity. ...
Whole exome sequencing (WES) is a recently developed technique in genetics research that attempts to...
Background: De novo variants (DNVs) are currently not routinely evaluated as part of diagnostic whol...
Background: Parkinson’s disease (PD) is a complex disease with its monogenic forms accounting for le...
analysis to predict the analytic sensitivity of WES using pathogenic variants identified on targete...